VYGR$1.81+1.40%
Voyager Therapeutics, Inc.
Sector: Biological Products, (No Diagnostic Substances)Industry: BiotechnologyCountry: USExchange: Nasdaq
Mkt Cap:$111.22M
Float & O/S:50.31M / 61.62M
Inst Own:57.6%
DilutionScan read 33 of Voyager Therapeutics, Inc.'s SEC filings and found 1 warrant series, 2 ATM programs and 2 shelf registrations on file for VYGR. The latest dilution event on file is ATM sales on Jun 30, 2026. Analysis updated Oct 31, 2026.
